EGF816, EGF816, LEE011, LEE011
CLEE011X2X01B
Phase 2 small_molecule active
Quick answer
EGF816, EGF816, LEE011, LEE011 for Different types of advanced cancer is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Different types of advanced cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active